Table 1:
Age-standardised (World Standard Population) testicular cancer incidence rates per 100,000 person-years (2008–2012).
| Population | Number of Registries Included | 1978–1982 |
2008–2012 |
AAPC | AAPC 95% CI | ||
|---|---|---|---|---|---|---|---|
| Rate | 95% CI | Rate | 95% CI | (%) | |||
|
| |||||||
| Africa | |||||||
| Uganda | 1 | 0.3 | (0.1, 0.4) | −3.9 | (−10.5, 3.3) | ||
| Asia | |||||||
| China | 2 | 1.5 | (1.3, 1.6) | 1.5 | (1.3, 1.6) | 0.6 | (−1.3, 2.5) |
| India | 2 | 0.6 | (0.5, 0.6) | −1.1* | (−1.7, −0.4) | ||
| Japan | 3 | 1.3 | (1.2, 1.5) | 2.5 | (2.3, 2.7) | 2.1* | (1.5, 2.6) |
| Philippines | 1 | 0.8 | (0.6, 0.9) | −0.3 | (−2.4, 1.8) | ||
| Thailand | 1 | 0.5 | (0.3, 0.7) | −0.2 | (−2.9, 2.6) | ||
| Middle East | |||||||
| Israel | 1 | 2.1 | (1.8, 2.5) | 4.5 | (4.1, 4.8) | 2.7* | (1.6, 3.9) |
| Kuwait | 1 | 1.1 | (0.2, 1.9) | 1.9 | (1.4, 2.5) | 3.0* | (1.2, 4.8) |
| Central/Eastern Europe | |||||||
| Belarus | 1N | 2.3 | (2.2, 2.5) | 3.4* | (2.5, 4.4) | ||
| Czech Republic | 1N | 7.6 | (7.3, 7.9) | 2.2* | (1.3, 3.1) | ||
| Poland | 1 | 4.3 | (3.6, 5.0) | 4.1* | (3.3, 4.9) | ||
| Slovakia | 1N | 2.6 | (2.4, 2.9) | 8.6 | (8.0, 9.2) | 3.9* | (3.6, 4.2) |
| Northern Europe | |||||||
| Denmark | 1N | 7.8 | (7.3, 8.3) | 10.2 | (9.7, 10.8) | 0.8* | (0.4, 1.3) |
| Iceland | 1N | 3.0 | (1.6, 4.3) | 5.5 | (3.9, 7.0) | 1.9 | (−0.5, 4.3) |
| Finland1 | 1N | 1.5 | (1.3, 1.7) | 5.1 | (4.7, 5.5) | 4.2* | (3.6, 4.8) |
| Norway | 1N | 5.8 | (5.4, 6.3) | 11.5 | (10.9, 12.1) | 2.4* | (2.0, 2.8) |
| Sweden1 | 1N | 3.3 | (3.1, 3.6) | 6.9 | (6.5, 7.2) | 2.2* | (1.8, 2.7) |
| Estonia | 1N | 3.3 | (2.7, 3.9) | 3.1* | (2.1, 4.1) | ||
| Latvia | 1N | 3.4 | (2.8, 4.0) | 4.5* | (3.8, 5.3) | ||
| Lithuania | 1N | 2.6 | (2.2, 2.9) | 3.6* | (1.0, 6.2) | ||
| Western Europe | |||||||
| France | 4 | 3.5 | (3.0, 3.9) | 7.6 | (7.0, 8.2) | 2.5* | (2.1, 2.9) |
| Ireland | 1N | 6.8 | (6.4, 7.3) | 2.6 | (−0.6, 6.0) | ||
| The Netherlands | 1N | 8.5 | (8.2, 8.8) | 4.0* | (3.5, 4.5) | ||
| United Kingdom | 11 | 6.6 | (6.5, 6.8) | 1.0 | (−0.3, 2.3) | ||
| Southern Europe | |||||||
| Croatia | 1N | 7.6 | (7.1, 8.2) | 6.0* | (2.5, 9.5) | ||
| Italy | 2 | 2.7 | (1.8, 3.6) | 6.1 | (4.9, 7.3) | 3.2* | (2.1, 4.4) |
| Malta | 1N | 5.6 | (4.2, 6.9) | 3.6 | (−1.5, 9.1) | ||
| Slovenia | 1N | 8.8 | (8.0, 9.6) | 3.7* | (2.3, 5.2) | ||
| Spain | 2 | 1.3 | (0.7, 1.8) | 4.2 | (3.4, 5.1) | 4.3* | (2.9, 5.8) |
| Austria | 1N | 8.2 | (7.0, 9.5) | 1.2* | (0.1, 2.3) | ||
| Germany | 1 | 5.3 | (4.4, 6.2) | 8.6 | (7.4, 9.8) | 1.5* | (0.9, 2.0) |
| Switzerland | 3 | 6.8 | (5.8, 7.8) | 8.9 | (7.9, 9.9) | 0.5 | (−0.3, 1.3) |
| North America | |||||||
| Canada | 8 | 3.3 | (3.2, 3.5) | 5.5 | (5.3, 5.7) | 1.5* | (1.1, 1.9) |
| Costa Rica | 1N | 1.6 | (0.8, 2.4) | 3.6 | (3.2, 4.0) | 3.4* | (2.4, 4.5) |
| Puerto Rico | 1N | 1.0 | (0.8, 1.2) | 3.2 | (2.9, 3.6) | 4.1* | (3.5, 4.8) |
| United States2 | 1 | 3.8 | (3.7, 4.0) | 5.5 | (5.3, 5.7) | 1.1* | (0.9, 1.4) |
| Latin America and Caribbean | |||||||
| Brazil | 1 | 1.6 | (1.1, 2.0) | 4.0* | (0.2, 7.9) | ||
| Colombia | 1 | 2.6 | (2.1, 3.0) | 2.1* | (0.6, 3.5) | ||
| Ecuador | 1 | 5.3 | (4.6, 6.0) | 2.5* | (1.3, 3.8) | ||
| Oceania | |||||||
| Australia | 5 | 6.3 | (6.1, 6.5) | 1.9* | (1.2, 2.6) | ||
| New Zealand | 1N | 6.9 | (6.4, 7.4) | 1.0* | (0.5, 1.6) | ||
*
Statistically significant at the 0.05 level.
N
Registry contributed national level data.
1
Data provided by the NORDCAN database for years 2008–2012.
2
Includes SEER 9 registries (Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Fransisco -Oakland, Seattle-Puget Sound, and Utah).